Breaking Down Geographic Barriers in Clinical Research

What if patients could participate in clinical trials from their living room instead of driving hours to a site? Tyler Van Horn, CEO of Science 37, explains how their direct-to-patient site model works. With one site covering all 50 states, Science 37 sends research-grade nurses to patients' homes, ships investigational products directly to participants, and uses telemedicine for investigator oversight. Tyler breaks down how they maintain quality (they've passed three FDA inspections with no findings), manage the logistics of home visits, educate sponsors on this approach, and create a high-touch patient experience that leads to better retention rates. If you've been curious about how decentralized trials actually work in practice or how to reach patients in research deserts, this conversation is for you.